Abbott has positive data for Esprit drug-eluting resorbable scaffold
Abbott (NYSE:ABT) today announced data supporting its Esprit BTK everolimus-eluting resorbable scaffold system.
Source: massdevice.com
Abbott Esprit News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Abbott Esprit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Abbott Esprit Today - Breaking & Trending Today